The global graft versus host disease (GvHD) treatment market is expected to witness strong growth in the coming years, according to a new report by Transparency Market Research. Graft versus host disease is a serious complication that can occur after an allogeneic stem cell or bone marrow transplant. When the donor’s immune cells, or graft, view the recipient’s body as foreign and attack the recipient’s tissues and organs, it results in GvHD.
𝐆𝐞𝐭 𝐲𝐨𝐮𝐫 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐭𝐨 𝐁𝐨𝐨𝐬𝐭 𝐘𝐨𝐮𝐫 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐊𝐧𝐨𝐰𝐥𝐞𝐝𝐠𝐞 𝐟𝐨𝐫 𝐕𝐚𝐥𝐮𝐚𝐛𝐥𝐞 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=59799
The global GvHD treatment market is driven by the rising prevalence of cancers requiring stem cell transplants as part of treatment. Advancements in transplantation procedures and success rates are also fueling the market growth. However, high costs associated with clinical trials for new treatment therapies pose a challenge.
Based on type of GvHD, the market is segmented into acute GvHD and chronic GvHD. In terms of treatment, the market covers mTOR inhibitors, tyrosine kinase inhibitors, monoclonal antibodies, etanercept, thalidomide, and others. Regionally, North America dominates the global market due to the high incidence of GvHD cases. Asia Pacific is expected to witness the highest growth over the forecast period.
Major companies operating in the global GvHD treatment market include Novartis AG, Bristol-Myers Squibb, Pfizer, F. Hoffmann-La Roche, AbbVie, Astellas Pharma, Merck & Co., Takeda Pharmaceutical, Abbott, Eli Lilly, Merck & Co., Inc., Sanofi, Neovii Pharmaceuticals AG, Soligenix, Mesoblast Ltd, Johnson & Johnson Services, Inc., Mallinckrodt, ElsaLys Biotech SA, Incyte, and Kiadis Pharma. These players are involved in developing novel therapies and expanding geographically for market dominance.
With the rising cancer burden worldwide, the need for stem cell transplants will continue propelling the GvHD treatment market in the coming years. Furthermore, ongoing research for more effective and targeted therapies will further support the market expansion through the forecast period.
𝐀𝐛𝐨𝐮𝐭 𝐔𝐬 𝐓𝐫𝐚𝐧𝐬𝐩𝐚𝐫𝐞𝐧𝐜𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.
Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.
𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐔𝐬
Nikhil Sawlani
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453